The shares of QUALCOMM Incorporated (NASDAQ:QCOM) started off the last trading session with the price of $59.77 while closing the day with the price of $59.7. The shares of QUALCOMM Incorporated (NASDAQ:QCOM) Fell -4.95% with the Loss of -0.07 points.
The shares of QUALCOMM Incorporated (NASDAQ:QCOM) traded with the day volume of 38.51 Million shares whereas its average trading volume is 11.33 Million.
While analyzing the past performance of the stock we can see that the shares of QUALCOMM Incorporated (NASDAQ:QCOM) Loss -3.93% in the last week while Falling -6.7% in the last month. Past quarter performance shows the red light with -7.07%. The semi-annual and annual performance shows 18.05% and 2.12% respectively.
Some critical values of the shares of QUALCOMM Incorporated (NASDAQ:QCOM) to be discussed here are: the beta which shows the value at 1.37 while Average True Range of QUALCOMM Incorporated (NASDAQ:QCOM) demonstrate the value at 2.05. The weekly and monthly volatility of the shares of QUALCOMM Incorporated (NASDAQ:QCOM) are indicated at 2.22% and 2.61%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 36.06.
While studying the financial position of the shares of QUALCOMM Incorporated (NASDAQ:QCOM), we can see that the Market capitalization of the company is at 86.68 Billion. The shares outstanding for the company is 1.45 Billion and the shares float stands at 1.45 Billion. The income of the company stand at -3607000000 while the sales stand at 22.36 Billion.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -2.45, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 3.88, the Return on Asset ROA stood at -0.067 and the Return on Equity ROE depicted at -0.142 while Return on Investment ROI is at 0.036.
Proteostasis Therapeutics, Inc. (NASDAQ:PTI)
Proteostasis Therapeutics, Inc. (NASDAQ:PTI) started its previous trading session at $6.27 and closed at $6.38 showing a Rise of 54.11 Percent.
The Company traded with an average Volume of 1.02 Million whereas, its Day Volume stood at 35.06 Million.
Looking at the performance of the stock, Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Gain 89.32% in the last week in its shares price and 132.85% in the last month. Quarterly performance shows a green of 164.73 Percent while Semi-Annual and Annual performances shows a 196.74 and -50.85 percent respectively.
Beta for Proteostasis Therapeutics, Inc. (NASDAQ:PTI) stands at 0 while the ATR (average true range) is at 0.56. The Stock’s Weekly and Monthly Volatility is 12.12% and 10.22% respectively showing a RSI value of 82.66.
While studying the financial position of the shares of Proteostasis Therapeutics, Inc. (NASDAQ:PTI), we can see that the Market capitalization of the company is at 185.02 Million. The shares outstanding for the company is 29 Million and the shares float stands at 27.88 Million.
The Company generated an income of -55400000 and the sales of 7.8 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-2.21 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 23.72 respectively.
The Return on Assets stands at -0.766, ROE shows a value of -0.931 and ROI for Proteostasis Therapeutics, Inc. (NASDAQ:PTI) is -0.46 as of Trailing Twelve Months period.
